India · Delayed Price · Currency is INR Novartis India Statistics
Total Valuation
Novartis India has a market cap or net worth of INR 36.74 billion. The enterprise value is 30.10 billion.
| Market Cap | 36.74B |
| Enterprise Value | 30.10B |
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | Jul 23, 2025 |
Share Statistics
Novartis India has 24.69 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 24.69M |
| Shares Outstanding | 24.69M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.17% |
| Float | 6.70M |
Valuation Ratios
The trailing PE ratio is 39.43.
| PE Ratio | 39.43 |
| Forward PE | n/a |
| PS Ratio | 10.37 |
| PB Ratio | 4.49 |
| P/TBV Ratio | 4.49 |
| P/FCF Ratio | 79.20 |
| P/OCF Ratio | 78.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.98, with an EV/FCF ratio of 64.87.
| EV / Earnings | 32.30 |
| EV / Sales | 8.49 |
| EV / EBITDA | 31.98 |
| EV / EBIT | 32.66 |
| EV / FCF | 64.87 |
Financial Position
The company has a current ratio of 5.30, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.30 |
| Quick Ratio | 4.86 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.07 |
| Interest Coverage | 73.13 |
Financial Efficiency
Return on equity (ROE) is 11.63% and return on invested capital (ROIC) is 42.03%.
| Return on Equity (ROE) | 11.63% |
| Return on Assets (ROA) | 5.98% |
| Return on Invested Capital (ROIC) | 42.03% |
| Return on Capital Employed (ROCE) | 11.06% |
| Weighted Average Cost of Capital (WACC) | 4.15% |
| Revenue Per Employee | 63.27M |
| Profits Per Employee | 16.64M |
| Employee Count | 56 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, Novartis India has paid 364.80 million in taxes.
| Income Tax | 364.80M |
| Effective Tax Rate | 28.14% |
Stock Price Statistics
The stock price has increased by +35.65% in the last 52 weeks. The beta is -0.02, so Novartis India's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | +35.65% |
| 50-Day Moving Average | 1,067.50 |
| 200-Day Moving Average | 909.11 |
| Relative Strength Index (RSI) | 83.46 |
| Average Volume (20 Days) | 6,382 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis India had revenue of INR 3.54 billion and earned 931.80 million in profits. Earnings per share was 37.74.
| Revenue | 3.54B |
| Gross Profit | 1.56B |
| Operating Income | 921.50M |
| Pretax Income | 1.30B |
| Net Income | 931.80M |
| EBITDA | 941.00M |
| EBIT | 921.50M |
| Earnings Per Share (EPS) | 37.74 |
Balance Sheet
The company has 6.68 billion in cash and 32.10 million in debt, with a net cash position of 6.64 billion or 269.12 per share.
| Cash & Cash Equivalents | 6.68B |
| Total Debt | 32.10M |
| Net Cash | 6.64B |
| Net Cash Per Share | 269.12 |
| Equity (Book Value) | 8.18B |
| Book Value Per Share | 331.34 |
| Working Capital | 6.23B |
Cash Flow
In the last 12 months, operating cash flow was 467.30 million and capital expenditures -3.40 million, giving a free cash flow of 463.90 million.
| Operating Cash Flow | 467.30M |
| Capital Expenditures | -3.40M |
| Depreciation & Amortization | 19.50M |
| Net Borrowing | -22.00M |
| Free Cash Flow | 463.90M |
| FCF Per Share | 18.79 |
Margins
Gross margin is 44.02%, with operating and profit margins of 26.01% and 26.30%.
| Gross Margin | 44.02% |
| Operating Margin | 26.01% |
| Pretax Margin | 36.59% |
| Profit Margin | 26.30% |
| EBITDA Margin | 26.56% |
| EBIT Margin | 26.01% |
| FCF Margin | 13.09% |
Dividends & Yields
This stock pays an annual dividend of 25.00, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | 25.00 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 66.25% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 1.77% |
| Earnings Yield | 2.54% |
| FCF Yield | 1.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |